glp 1 medication How GLP-1 medications are transforming diabetes and weight loss treatment Researchers find GLP-1 medications safe

Since its discovery in the 1990s by the team of Professor Predrag Sikiric at the University of Zagreb, this pentadecapeptide has attracted growing interest from the scientific community and healthcare practitioners

doi: 10.1177/10600280211053867

Experimental literature explores its interaction with laboratory models of cell cycle regulation and peptide-mediated processes

Chronic ICV administration of oxyntomodulin, a GLP-1R agonist, in mice decreased body weight despite having no significant effects on food intake (Lockie et al., 2012)

This infusion should be administered 24-72 hours prior to receiving any vaccine

BPC-157 is one of the most compelling peptides in regenerative and functional medicine